Risk of Acute Pancreatitis in Users of Finasteride: A Population-based Case-control Study

Journal of Clinical Gastroenterology

Volumn 38, Issue 3, 2004, Pages 276-278

  Floyd, Andrea ^a,b   Pedersen, Lars ^a   Nielsen, Gunnar Lauge ^a,b   Thorlacius Ussing, Ole ^b   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute pancreatitis; Case control; Drug associated pancreatitis; Epidemiology; Finasteride

Indexed keywords

FINASTERIDE;

ACUTE PANCREATITIS; ADULT; AGED; ALCOHOLISM; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DATA BASE; DENMARK; DISEASE PREDISPOSITION; GALLSTONE; HOSPITAL ADMISSION; HUMAN; HYPERCALCEMIA; HYPERLIPIDEMIA; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; RISK;

ACUTE DISEASE; CASE-CONTROL STUDIES; DENMARK; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; RISK; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 1242285122     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200403000-00015     Document Type: Article

References (19)

1. Shakir S, Pearce G, Mann RD. Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription-event monitoring data. BJU Int. 2001;87:789-796.
2. Ornstein DK, Beiser JA, Andriole GL. Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer. BJU Int. 1999;83:43-46.
3. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998;338:557-563.
4. Stough DB, Rao NA, Kaufmann KL, et al. Finasteride improves male pattern hair loss in a randomized study in identical twins. Eur J Dermatol. 2002;12:32-37.
5. Barth JH. Should men still go bald gracefully? Lancet. 2000;355:161-162.
6. Floyd AK, Pedersen L, Nielsen GL, et al. Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: a register-based study from 1981-2000. Scand J Gastroenterol. 2002;37:1461-1465.
7. Lin YH, Perng CL, Lin HJ, et al. Acute pancreatitis possibly related to finasteride. J Clin Gastroenterol. 2001;32:276.
8. Strom BL. Study designs available for pharmacoepidemiology studies. In: Strom BL, Ed. What Is Pharmacoepidemiology? 2nd ed. New York, NY: John Wiley & Sons; 1999:15-27.
9. Neoptolemos JP, Raraty M, Finch M, et al. Acute pancreatitis: the substantial human and financial costs. Gut. 1998;42:886-891.
10. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
11. Sørensen HT. Regional administrative health registries as a resource in clinical epidemiology. Int J Risk Safety Med. 1997;10:1-22.
12. Szklo M, Nieto NF. Basic study design in analytical epidemiology. In: Szklo M, Nieto NF, eds. Epidemiology: Beyond the Basics. New York, NY: Aspen; 2000:34-36.
13. Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44:445-448.
14. Nielsen GL, Sørensen HT, Zhou W, et al. The Pharmacoepidemiologic Prescription Database of North Jutland - a valid tool in pharmacoepidemiological research. Int J Risk Safety Med. 1997;10:203-205.
15. Capella D. Descriptive tools and analysis. WHO Reg Publ Eur Ser. 1993;45:55-78.
16. Carnaille B, Oudar C, Pattou F, et al. Pancreatitis and primary hyperparathyroidism: forty cases. Aust N Z J Surg. 1998;68:117-119.
17. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198-1210.
18. Olsen JH, Sorensen HT, Friis S, et al. Cancer risk in users of calcium channel blockers. Hypertension. 1997;29:1091-1094.
19. Blomgren KB, Sundstrom A, Steineck G, et al. A Swedish case-control network for studies of drug-induced morbidity-acute pancreatitis. Eur J Clin Pharmacol. 2002;58:275-283.